Literature DB >> 16114099

Molecular dynamics simulation of human neurohypophyseal hormone receptors complexed with oxytocin-modeling of an activated state.

Magdalena J Slusarz1, Rafał Slusarz, Jerzy Ciarkowski.   

Abstract

The neurohypophyseal hormone oxytocin (CYIQNCPLG-NH(2), OT) is involved in the control of labor, secretion of milk and many social and behavioral functions via interaction with its receptors (OTR) located in the uterus, mammary glands and peripheral tissues, respectively. In this paper we propose the interactions responsible for OT binding and selectivity to OTR versus vasopressin ([F3,R8]OT, AVP) receptors: V1aR and V2R, all three belonging to the Class A G protein-coupled receptors (GPCRs). Three-dimensional models of the activated receptors were constructed using a multiple sequence alignment and the activated rhodopsin-transducin (MII-Gt) prototype [Slusarz and Ciarkowski, 2004] as a template. The 1 ns unconstrained molecular dynamics (MD) of three pairs of receptor-OT complexes (two complexes per each receptor) immersed in the fully hydrated 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylcholine (POPC) lipid bilayer was conducted in the AMBER 7.0 force field. The relaxed models of ligand-receptor complexes were used to identify the putative binding sites of OT. The stabilizing interactions with conserved Gln residues in all complexes were identified. The nonconserved hydrophobic residues were proposed as responsible for OTR-OT selectivity and ligand recognition. These results provide guidelines for experimental site-directed mutagenesis and if confirmed, they may be helpful in designing new selective OT analogs with both agonistic or antagonistic properties. Copyright (c) 2005 European Peptide Society and John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16114099     DOI: 10.1002/psc.713

Source DB:  PubMed          Journal:  J Pept Sci        ISSN: 1075-2617            Impact factor:   1.905


  3 in total

1.  Oxytocin-Gly-Lys-Arg: a novel cardiomyogenic peptide.

Authors:  Bogdan A Danalache; Jolanta Gutkowska; Magdalena J Slusarz; Irena Berezowska; Marek Jankowski
Journal:  PLoS One       Date:  2010-10-26       Impact factor: 3.240

Review 2.  A novel therapeutic effect of statins on nephrogenic diabetes insipidus.

Authors:  Leonilde Bonfrate; Giuseppe Procino; David Q-H Wang; Maria Svelto; Piero Portincasa
Journal:  J Cell Mol Med       Date:  2015-01-16       Impact factor: 5.310

Review 3.  Insights into the molecular evolution of oxytocin receptor ligand binding.

Authors:  Johannes Koehbach; Thomas Stockner; Christian Bergmayr; Markus Muttenthaler; Christian W Gruber
Journal:  Biochem Soc Trans       Date:  2013-02-01       Impact factor: 5.407

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.